January 18, 2022
VIA CORRESPONDENCE
Michelle Miller
Mark Brunhofer
Division of Corporation Finance
Office of Finance
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: | Jiayin Group Inc. |
Form 20-F for the Fiscal Year Ended December 31, 2020 |
Filed April 30, 2021 |
File No. 001-38806 |
Dear Ms. Miller and Mr. Brunhofer:
This letter sets forth the response of Jiayin Group Inc. (the Company) to the comments contained in the letter dated January 4, 2022 from the staff (the Staff) of the Securities and Exchange Commission (the Commission) regarding the Companys annual report on Form 20-F for the fiscal year ended December 31, 2020 (the Form 20-F).
For ease of review, we have set forth below each of the numbered comments of the Staffs letter and the Companys responses thereto.
Form 20-F for the Fiscal Year Ended December 31, 2020
Item 3. Key Information, page 4
1. | We note your response to prior comment 4. Please disclose the roll-forward of the investment in subsidiaries and VIEs together with the VIE Consolidation Schedule previously provided in response to comment 7 of our September 20, 2021 letter in Item 3. Key InformationA. Selected Financial Data. |
Response: In light of the Staffs comments, we propose to add the VIE Consolidation Schedule (previously provided in response to comment 7 of the Commissions letter dated September 20, 2021) and the roll-forward of the investment in subsidiaries and VIEs (previously provided in response to comment 4 of the Commissions letter dated November 19, 2021) in Item 3. Key InformationA. Selected Financial Data in a future amendment to the Form 20-F as follows:
VIE Consolidation Schedule
The following tables set forth the summary consolidated balance sheets data as of December 31, 2018, 2019 and 2020 of (i) the Parent, (ii) the consolidated VIE and its subsidiaries and (iii) the Non-VIE subsidiaries, and the summary of the consolidated statement of income and cash flows for the years ended December 31, 2018, 2019 and 2020. Our consolidated financial statements are prepared and presented in accordance with accounting principles generally accepted in the United States, or U.S. GAAP. Our and the consolidated VIEs historical results are not necessarily indicative of results expected for future periods. You should read this information together with our consolidated financial statements and the related notes and Item 5. Operating and Financial Review and Prospects included elsewhere in this annual report.
1
As of December 31, 2020 | ||||||||||||||||||||
Parent | Consolidated VIE and its subsidiaries |
Non-VIE subsidiaries |
Eliminating adjustments between (i) the Parent and its subsidiaries and (ii) the Consolidated VIE and its subsidiaries |
Consolidated total |
||||||||||||||||
(RMB in thousands) | ||||||||||||||||||||
Assets |
||||||||||||||||||||
Cash and cash equivalents |
21,213 | 12,469 | 83,638 | | 117,320 | |||||||||||||||
Accounts receivable and contract assets, net |
| 9 | 158,055 | | 158,064 | |||||||||||||||
Investments in subsidiaries and VIEs |
(652,193 | ) | | 87,551 | 652,193 | 87,551 | ||||||||||||||
Intercompany balances* |
167,887 | 117,938 | (285,825 | ) | | | ||||||||||||||
Other assets |
855 | 52,612 | 108,970 | | 162,437 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total assets |
(462,238 | ) | 183,028 | 152,389 | 652,193 | 525,372 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Liabilities |
||||||||||||||||||||
Tax payables |
| 232,730 | 46,653 | | 279,383 | |||||||||||||||
Other payables related to the deposal of Shanghai Caiyin |
| 566,532 | | | 566,532 | |||||||||||||||
Other liabilities |
2,385 | 50,602 | 90,235 | | 143,222 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total liabilities |
2,385 | 849,864 | 136,888 | | 989,137 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total net assets/(liabilities) |
(464,623 | ) | (666,836 | ) | 15,501 | 652,193 | (463,765 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
* | Intercompany balances resulted from regular transactions in the business operations of the entities, and no service fees were charged by Shanghai Kunjia. |
2
As of December 31, 2019 | ||||||||||||||||||||
Parent | Consolidated VIE and its subsidiaries |
Non-VIE subsidiaries |
Eliminating adjustments between (i) the Parent and its subsidiaries and (ii) the Consolidated VIE and its subsidiaries |
Consolidated total |
||||||||||||||||
(RMB in thousands) | ||||||||||||||||||||
Assets |
||||||||||||||||||||
Cash and cash equivalents |
27,223 | 54,602 | 40,324 | | 122,149 | |||||||||||||||
Amounts due from related parties |
124,862 | 1,651 | 4,209 | | 130,722 | |||||||||||||||
Accounts receivable and contract assets, net |
| 110,219 | 28,945 | | 139,164 | |||||||||||||||
Short-term investment, net |
69,618 | | | | 69,618 | |||||||||||||||
Investments in subsidiaries and VIEs |
(1,003,436 | ) | | 3,826 | 1,003,436 | 3,826 | ||||||||||||||
Intercompany balances* |
44,695 | 52,649 | (97,344 | ) | | | ||||||||||||||
Other assets |
1,117 | 196,532 | 37,944 | | 235,593 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total assets |
(735,921 | ) | 415,653 | 17,904 | 1,003,436 | 701,072 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Liabilities |
||||||||||||||||||||
Refund liabilities |
| 180,104 | | | 180,104 | |||||||||||||||
Tax payables |
| 164,444 | 14,977 | | 179,421 | |||||||||||||||
Other payables related to the deposal of Shanghai Caiyin |
| 839,830 | | | 839,830 | |||||||||||||||
Other liabilities |
5,933 | 186,047 | 51,336 | | 243,316 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total liabilities |
5,933 | 1,370,425 | 66,313 | | 1,442,671 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total net assets/(liabilities) |
(741,854 | ) | (954,772 | ) | (48,409 | ) | 1,003,436 | (741,599 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|
* | Intercompany balances resulted from regular transactions in the business operations of the entities, and no service fees were charged by Shanghai Kunjia. |
As of December 31, 2018 | ||||||||||||||||||||
Parent | Consolidated VIE and its subsidiaries |
Non-VIE subsidiaries |
Eliminating (i) the Parent and its |
Consolidated total |
||||||||||||||||
(RMB in thousands) | ||||||||||||||||||||
Assets |
||||||||||||||||||||
Cash and cash equivalents |
| 41,441 | | | 41,441 | |||||||||||||||
Restricted cash |
| 41,500 | | | 41,500 | |||||||||||||||
Accounts receivable, net |
| 336,849 | | | 336,849 | |||||||||||||||
Contract assets, net |
| 203,080 | | | 203,080 | |||||||||||||||
Investments in subsidiaries and VIEs |
(1,652,006 | ) | | | 1,652,006 | | ||||||||||||||
Other assets |
| 179,009 | | | 179,009 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total assets |
(1,652,006 | ) | 801,879 | | 1,652,006 | 801,879 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Liabilities |
||||||||||||||||||||
Liabilities from the investor assurance program |
| 1,547,072 | | | 1,547,072 | |||||||||||||||
Tax payables |
| 422,177 | | | 422,177 | |||||||||||||||
Other liabilities |
| 484,636 | | | 484,636 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total liabilities |
| 2,453,885 | | | 2,453,885 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total net assets/(liabilities) |
(1,652,006 | ) | (1,652,006 | ) | | 1,652,006 | (1,652,006 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
3
For the year ended December 31, 2020 | ||||||||||||||||||||
Parent | Consolidated VIE and its subsidiaries |
Non-VIE subsidiaries |
Eliminating adjustments between (i) the Parent and its subsidiaries and (ii) the Consolidated VIE and its subsidiaries |
Consolidated total |
||||||||||||||||
(RMB in thousands) | ||||||||||||||||||||
Net revenue |
| 624,868 | 1,057,868 | (382,576 | ) | 1,300,160 | ||||||||||||||
Total operating cost and expenses |
(6,740 | ) | (394,453 | ) | (979,436 | ) | 382,576 | (998,053 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
(Loss)/Income from operations |
(6,740 | ) | 230,415 | 78,432 | | 302,107 | ||||||||||||||
Equity in earnings of subsidiaries and VIEs |
319,091 | | | (319,091 | ) | | ||||||||||||||
Net income |
252,883 | 254,283 | 61,991 | (319,091 | ) | 250,066 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
4
For the year ended December 31, 2019 | ||||||||||||||||||||
Parent | Consolidated VIE and its subsidiaries |
Non-VIE subsidiaries |
Eliminating adjustments between (i) the Parent and its subsidiaries and (ii) the Consolidated VIE and its subsidiaries |
Consolidated total |
||||||||||||||||
(RMB in thousands) | ||||||||||||||||||||
Net revenue |
| 2,151,165 | 189,473 | (110,462 | ) | 2,230,176 | ||||||||||||||
Total operating cost and expenses |
(2,886 | ) | (1,567,424 | ) | (235,659 | ) | 110,462 | (1,695,507 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
(Loss)/Income from operations |
(2,886 | ) | 583,741 | (46,186 | ) | | 534,669 | |||||||||||||
Equity in earnings of subsidiaries and VIEs |
525,722 | | | (525,722 | ) | | ||||||||||||||
Net income |
527,747 | 571,227 | (46,067 | ) | (525,722 | ) | 527,185 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
For the year ended December 31, 2018 | ||||||||||||||||||||
Parent | Consolidated VIE and its subsidiaries |
Non-VIE subsidiaries |
Eliminating adjustments between (i) the Parent and its subsidiaries and (ii) the Consolidated VIE and its subsidiaries |
Consolidated total |
||||||||||||||||
(RMB in thousands) | ||||||||||||||||||||
Net revenue |
| 2,881,940 | | | 2,881,940 | |||||||||||||||
Total operating cost and expenses |
| (2,196,734 | ) | | | (2,196,734 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
(Loss)/Income from operations |
| 685,206 | | | 685,206 | |||||||||||||||
Equity in earnings of subsidiaries and VIEs |
611,758 | | | (611,758 | ) | | ||||||||||||||
Net income |
611,758 | 611,758 | | (611,758 | ) | 611,758 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
For the year ended December 31, 2020 | ||||||||||||||||||||
Parent | Consolidated VIE and its subsidiaries |
Non-VIE subsidiaries |
Eliminating adjustments between (i) the Parent and its subsidiaries and (ii) the Consolidated VIE and its subsidiaries |
Consolidated total |
||||||||||||||||
(RMB in thousands) | ||||||||||||||||||||
Net cash (used in) provided by operating activities |
(38,027 | ) | (40,071 | ) | 42,593 | | (35,505 | ) | ||||||||||||
Net cash provided by (used in) investing activities |
37,372 | (62 | ) | (4,084 | ) | | 33,226 | |||||||||||||
Net cash provided by financing activities |
6,982 | | 3,613 | | 10,595 |
5
For the year ended December 31, 2019 | ||||||||||||||||||||
Parent | Consolidated VIE and its subsidiaries |
Non-VIE subsidiaries |
Eliminating adjustments between (i) the Parent and its subsidiaries and (ii) the Consolidated VIE and its subsidiaries |
Consolidated total |
||||||||||||||||
(RMB in thousands) | ||||||||||||||||||||
Net cash (used in) provided by operating activities |
(42,792 | ) | 19,465 | 49,618 | | 26,291 | ||||||||||||||
Net cash used in investing activities |
(191,401 | ) | (35,505 | ) | (7,272 | ) | | (234,178 | ) | |||||||||||
Net cash provided by (used in) financing activities |
255,928 | (12,299 | ) | 1,045 | | 244,674 |
For the year ended December 31, 2018 | ||||||||||||||||||||
Parent | Consolidated VIE and its subsidiaries |
Non-VIE subsidiaries |
Eliminating adjustments between (i) the Parent and its subsidiaries and (ii) the Consolidated VIE and its subsidiaries |
Consolidated total |
||||||||||||||||
(RMB in thousands) | ||||||||||||||||||||
Net cash used in operating activities |
| (228,368 | ) | | | (228,368 | ) | |||||||||||||
Net cash used in investing activities |
| (16,423 | ) | | | (16,423 | ) | |||||||||||||
Net cash used in financing activities |
| (433,600 | ) | | | (433,600 | ) |
The following table sets forth the roll-forward of the line item titled investments in subsidiaries and VIEs in the Parents financial statements:
Roll-forward of investments in subsidiaries and VIEs |
Investments in subsidiaries and VIEs |
|||
(RMB in thousands) |
||||
Balance at January 1, 2018 |
(1,931,542 | ) | ||
Equity in earnings of VIEs |
611,758 | |||
Equity in earnings of subsidiaries |
| |||
Dividend distributed to shareholders* |
(400,000 | ) | ||
Share-based compensation** |
67,778 | |||
|
|
|||
Balance at December 31, 2018 |
(1,652,006 | ) | ||
Equity in earnings of VIEs |
571,227 | |||
Equity in earnings of subsidiaries |
(45,505 | ) | ||
Share-based compensation offset by capitalized IPO expenses incurred by subsidiaries and VIEs** |
126,008 | |||
Foreign currency translation |
(3,160 | ) | ||
|
|
|||
Balance at December 31, 2019 |
(1,003,436 | ) | ||
Equity in earnings of VIEs |
254,283 | |||
Equity in earnings of subsidiaries |
64,808 | |||
Share-based compensation** |
30,652 | |||
Foreign currency translation |
1,500 | |||
|
|
|||
Balance at December 31, 2020 |
(652,193 | ) | ||
|
|
* | Cash dividends paid by a subsidiary on behalf of the parent to the Groups shareholders. |
** | Share-based compensation expense attributable to subsidiaries and VIEs accounted for as investments in subsidiaries and VIEs. In 2019, the amount was offset by IPO expenses incurred by subsidiaries and VIEs on behalf of the parent. |
6
Risk Factors, page 6
2. | We note your response to prior comment 5. Please disclose whether your auditor is subject to the determinations announced by the PCAOB on December 16, 2021 and update your disclosure to reflect that pursuant to the HFCAA, the PCAOB has issued its report notifying the Commission of its determination that it is unable to inspect or investigate completely accounting firms headquartered in mainland China or Hong Kong. |
Response: In light of the Staffs comments, we propose to revise the referenced risk factor disclosure in our response to prior comment 5 as follows, with the added disclosure underlined and the removed disclosure crossed out for ease of reference:
The Accelerating Holding Foreign Companies Accountable Act, which, if enacted, would reduce the time period before our ADSs may be prohibited from trading or delisted. The delisting of our ADSs, or the threat of their being delisted, may materially and adversely affect the value of your investment. Additionally, the inability of the PCAOB to conduct adequate inspections deprives our investors with the benefits of such inspections.
The Companys financial statements as of December 31, 2020 and for the year ended December 31, 2020 contained in the Form 20-F have been audited by Marcum Bernstein & Pinchuk LLP, or MBP, an independent registered public accounting firm that is headquartered in Manhattan, New York. MBP is a firm registered with the U.S. Public Company Accounting Oversight Board, or the PCAOB, and is required by the laws of the United States to undergo regular inspections by the PCAOB to assess its compliance with the laws of the United States and professional standards. According to Article 177 of the PRC Securities Law (last amended in March 2020), no overseas securities regulator is allowed to directly conduct investigation or evidence collection activities in China. Accordingly, without the consent of the competent PRC securities regulators and relevant authorities, no organization or individual may provide the documents and materials relating to securities business activities to overseas parties. MBP has been inspected by the PCAOB on a regular basis with the last inspection in 2018 and an ongoing inspection that started in November 2020. However, recent developments with respect to audits of China-based companies create uncertainty about the ability of our auditor to fully cooperate with the PCAOBs request for audit workpapers without the approval of the Chinese authorities. The PCAOB is currently able to conduct inspections of U.S. audit firms where audit workpapers are located in China, however, PCAOBs requests for workpapers are subject to approval by Chinese authorities. The audit workpapers for our and the consolidated VIEs operations are located in China. As a result, our investors may be deprived of the benefits of PCAOBs oversight of our auditor, MBP, through such inspections.
The Companys financial statements as of December 31, 2018 and 2019 and for the years then ended
were audited by Deloitte Touche Tohmatsu Certified Public Accountants LLP, or Deloitte. Deloitte is headquartered in Shanghai, China with offices in other cities in China. As an auditor of companies that are registered with the SEC and trade
publicly in the United States, Deloitte is an independent registered public accounting firm registered with the PCAOB, and is required by the laws of the United States to undergo regular inspections by the PCAOB to assess their compliance with the
laws of the United States and professional standards. Because we Deloitte is not subject to PCAOB inspections and is subject to the PCAOB Determinations (as defined below). We have substantial operations within the PRC and
the PCAOB is currently unable to conduct inspections of the work of Deloitte as it relates to those operations without the approval of the Chinese authorities, Deloittes work related to our operations in China is not currently inspected by the
PCAOB.
This lack of PCAOB inspections of audit work performed in China prevents the PCAOB from regularly and fully evaluating audit work of any auditors that was performed in China, including that performed by Deloitte. As a result, investors may be deprived of the full benefits of PCAOB inspections, and thus may lose confidence in our reported financial information and procedures and the quality of our financial statements.
On December 18, 2020, the former U.S. president signed into law the Holding Foreign Companies Accountable Act, or the HFCAA. In essence, the HFCAA requires the SEC to prohibit foreign companies from listing securities on U.S. securities exchanges if a company retains a foreign accounting firm that cannot be inspected by the PCAOB for three consecutive years, beginning in 2021. On March 24, 2021, the SEC adopted interim final rules relating to the implementation of certain disclosure and documentation requirements of the HFCAA. On December 2, 2021, the SEC adopted amendments to finalize rules implementing the submission and disclosure requirements in the HFCAA which will go into effect 30 days after publication in the Federal Registrar. The SEC may propose additional rules or guidance that could impact us if our auditor is not subject to PCAOB inspection.
7
In addition, on June 22, 2021, the U.S. Senate passed a bill on the Accelerating Holding Foreign Companies Accountable Act which, if passed by the U.S. House of Representatives and signed into law, would amend the HFCAA and require the SEC to prohibit an issuers securities from trading on a U.S. stock exchange if its auditors is not subject to PCAOB inspections for two consecutive years instead of three, which could reduce the time period before our ADSs may be prohibited from trading or delisted.
On September 22, 2021, the PCAOB adopted a new rule related to its responsibilities under the HFCAA, which provides a framework for the PCAOB to use when determining, as contemplated under the HFCAA, whether it is unable to inspect or investigate completely registered public accounting firms located in a foreign jurisdiction because of a position taken by one or more authorities in that jurisdiction. The new rule became effective on November 4, 2021. On December 16, 2021, the PCAOB issued a report notifying the Commission of its determinations (the PCAOB Determinations) that they are unable to inspect or investigate completely PCAOB-registered public accounting firms headquartered in mainland China and in Hong Kong. The report sets forth lists identifying the registered public accounting firms headquartered in mainland China and Hong Kong, respectively, that the PCAOB is unable to inspect or investigate completely. As of the date hereof, our auditor, MBP, is not on such lists.
The prospect and implications of possible regulation on this subject, in addition to the prevailing requirements of the HFCAA, are uncertain. Such uncertainty could cause the market price of our ADSs to be materially and adversely affected, and our securities could be delisted or prohibited from being traded over-the-counter earlier than would be required by the HFCAA as it currently provides. If our securities are unable to be listed on another securities exchange by then, such a delisting would substantially impair your ability to sell or purchase our ADSs when you wish to do so, and the risk and uncertainty associated with a potential delisting would have a negative impact on the price of our ADSs.
* * *
8
If you have any additional questions or comments regarding the Form 20-F, please contact the undersigned at +86 13701697266, or Jin Chen, our Co-Chief Financial Officer, at +86 13738131533, or our U.S. counsel, Steve Lin at Kirkland & Ellis, at +8610 5737 9315 (office) or +86 18610495593 (mobile). Thank you.
Very truly yours, | ||
By: | /s/ Dinggui Yan | |
Name: Dinggui Yan | ||
Title: Chief Executive Officer |
cc: | Bei Bai, Co-Chief Financial Officer of Jiayin Group Inc. | |
Jin Chen, Co-Chief Financial Officer of Jiayin Group Inc. | ||
Steve Lin, Esq., Kirkland & Ellis | ||
Charles Yin, Marcum Bernstein & Pinchuk LLP |
9